Seven key genes—AKR1B1, CA2, FOS, CXCL2, SRC, ABCC1, and PLIN1—were found at the intersection between drug targets and HCC-related genes (Figure 4b). The gene discussed is FOS; the disease is hepatocellular carcinoma.